Sign in

Fidelity National Financial, Inc. FNF

Price 46.2 USD
as of 2026-09-03
50/100
Mixed
Quality45
Growth31
Balance-sheet strength40
Valuation81
Momentum37
Income87

Composite 50/100; the shares have moved about 29% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Growth ranks 31/100 — a moderate mark against it.

Case for

Income ranks 87/100 — a strong point in its favour. Valuation ranks 81/100 — a strong point in its favour.

Case against

Growth ranks 31/100 — a moderate mark against it. Momentum ranks 37/100 — a moderate mark against it. Balance-sheet strength ranks 40/100 — a slight mark against it.

What the company does FNF is a diversified U.S. specialty insurer and transaction services provider, operating through Title, F&G (life/annuity), and Corporate segments. It offers title insurance, escrow, real estate brokerage, mortgage tech, and PRT solutions, generating revenue from both recurring and transaction-linked streams.

Key financials ROE 10.5%, ROA 1.3%, and ROCE 1.8% reflect modest profitability. Gross/operating/net margins are 54.6%/19.2%/5.1%, with revenue and EPS growth at 16.7% and 200.0%, respectively. Debt/equity is 0.55 and interest coverage is 8.33, indicating manageable leverage.

Stock health Sideravia scores Valuation 82.5 (top quintile) and Income 87.2, offset by Quality 50.5 and Strength 40.6. Piotroski F-Score is 8/9 and Altman Z is 0.38, signaling resilience but elevated bankruptcy risk. Dividend yield is 4.2% with a 72.6% payout ratio.

Price vs fair value FNF trades at a PREMIUM of 15.00% to our fair-value estimate of 45.43 and a discount of 14.87% to the 12-month target of 61.40. - Analysts expect earnings growth next week (Zacks) - Forward P/E of 12.82 vs trailing 18.37 suggests optimism (Valuation pillar 82.5) - RSI(14) at 65.40 indicates near-term overbought conditions (Momentum 42.6)

Looking forward Forward PEG of 0.30 implies undervaluation relative to growth, but high payout ratio and leverage warrant caution. Title segment trends and PRT demand will drive near-term performance.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.